We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04799561
Previous Study | Return to List | Next Study

Teleprehabilitation for Surgical Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04799561
Recruitment Status : Recruiting
First Posted : March 16, 2021
Last Update Posted : September 30, 2021
Sponsor:
Collaborators:
Montreal General Hospital
Peri Operative Program, Montreal
Information provided by (Responsible Party):
Franco Carli, McGill University Health Centre/Research Institute of the McGill University Health Centre

Brief Summary:
There is a general concern that the backlog of cancer patients waiting for surgery during this period is going to increase and the general impact on patients isolated in their homes is going to cause potential physiological and psychological impairments. Therefore, we propose a distanced-delivered personalized home-based prehabilitation program to all cancer patients scheduled for surgery at the MUHC. The program will be delivered by qualified professionals, supported by technology provided by POP, to all cancer patients waiting for surgery, addressing the patients' risk factors in patients' pandemic reality perspective. Participant contacts will primarily occur virtually using technologies such as video conferencing and digital applications. This will enable us to continue to support people with cancer and deliver safe remote counseling by specialist healthcare providers in their own homes, whilst adhering to the Governmental guidelines on social distancing, self-isolation and shielding.

Condition or disease Intervention/treatment Phase
Abdominal Cancer Thoracic Cancer Behavioral: Multimodal Teleprehabilitation Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: This QI study will include one group of 100 patients who will receive distance-delivered support for all components of the home-based prehabilitation regimen in addition to 2 months of follow-up post-surgery. The program will include: exercise, nutrition, mental well-being and, if needed, smoking cessation. The technologies (a tablet and an active lifestyle watch) will be used to provide counselling, educate patients on lifestyle modifications and assess adherence remotely. Telephone calls will also be made on a weekly basis, if participants were unable to attend their video-conferencing counselling sessions.
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Virtual Prehabilitation of Surgical Cancer Patients in Times of the Covid-19 Pandemic
Actual Study Start Date : March 12, 2021
Estimated Primary Completion Date : September 15, 2022
Estimated Study Completion Date : December 15, 2022

Arm Intervention/treatment
Experimental: Teleprehabilitation cohort
Patients in this single-arm study will receive multimodal teleprehabilitation.
Behavioral: Multimodal Teleprehabilitation

Exercise Prescription: patients will be instructed on how to perform aerobic exercise (5 times/week: minimum 30-minute/day) and resistance training (3 times/week: 2-3 sets of 6-8 exercises repeated 8-12 times) at home. Exercise counseling will be weekly, using the video-conferencing application (Zoom).

Nutrition: nutritional status and dietary intake will initially be assessed by the nutritionist using zoom. All patients will receive daily whey protein supplements. Special precautions will be considered if patients have specific medical conditions.

Psychosocial intervention: Patients will have access to 1.5 hours of mental relaxation and coping mechanisms session within the first week of enrolment, using Zoom.

Smoking Cessation: Patients with smoking habits will meet with a respiratory specialist using Zoom, who will establish recommendations and contact the physician for the recommended smoking cessation protocol.

More counseling sessions will be provided as needed.

Other Name: Virtual Prehabilitation




Primary Outcome Measures :
  1. Recruitment Rate [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    Recruitment rate is defined as the number of participant recruited, compared to the number of eligible participant contacted.

  2. Adherence [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    based on self-reported measures and data from the polar watch, compared to prescribed intervention

  3. Program Completion Rate [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    The completion rate is defined as the number of participant completing all evaluations, compared to the number of participants recruited.

  4. frequency of Technological Failures [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    Frequency of technological failures is defined as the number of any technological challenge that would prevent participants from doing their interventions or contacting the research team member.

  5. Intervention-Related Adverse Events [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    Intervention-related adverse events is defined as any event that would cause harm to patients' physical or mental health.

  6. Rational for Refusal to Participate [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    When possible, patients' rational for refusing to participate in the project was collected.

  7. Rational for Low Compliance [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    When possible, participant's rational for low compliance to the project was collected.

  8. Rational for Drop-Outs [ Time Frame: Through study completion, for an expected duration of of 1.5 year. ]
    When possible, participant's rational for abandoning the project was collected.


Secondary Outcome Measures :
  1. 30 Second Sit-to-Stand [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessed the strength of the lower body, by sitting on a chair and standing up as many times as possible during 30 seconds.

  2. Time-Up and Go (TUG) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessed mobility, balance and locomotor performance associated to the tasks of walking and turning. The patients starts seated, and needs to stand up, walk turn around a cone and sit back down as fast as possible, the results is the numbers of seconds to perform the 3-meter distance to a cone and back.

  3. 2- or 6-Minute Walk Test [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    The 2- or 6-minute walk test is a functional capacity measure, surrogate to the assessment of cardiopulmonary capacities. The patient walks in a 20-meter corridor, back and forth, for 2 or 6 minutes and the result of the test is the distances traveled in meters.

  4. Abridged-Scored Patient-Generated Subjective Global Assessment (PG-SGA) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessed the state of nutrition, classification A, B or C ( B and C being states of nutritional risk).

  5. Body Mass Index (BMI) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessed the body composition, ranging 18 to 30 (>30 is obesity, and <18 is malnourished).

  6. CRP [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0) ]
    Assessed the degree of inflammation (>10mg/L indicates high inflammation )

  7. Serum Albumin [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0) ]
    Assessed the degree of inflammation (<35g/L indicates high inflammation)

  8. Duke Activity Status Index (DASI) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessed the level of physical activity and is measured in 12 questions, going up to a score of 58 (58 being the best score).

  9. Quality of Life (EQ5D) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessed the quality of life of the previous week, on a scale of 0 to 100 ( 100 being the best health).

  10. The Hospital Anxiety and Depression Scale (HADS) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessed the degree of anxiety and depression, separately, ranging from 0 to 18 respectively (18 being the worst score).

  11. Distress Thermometer [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    Assessment of the level of anxiety and distress, on a scale from 0 to 10 (10 being the worst score).

  12. The WHO Disability Assessment Schedule v2.0 (WHODAS) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    the WHO Disability Assessment Schedule is a scale of disability free survival, measured at different times,

  13. The Energy Expenditure (CHAMPS) [ Time Frame: During baseline assessment (beginning of prehabilitation period; T0), at the preoperative assessment (within the 24 hours prior to surgery; T1) and further at the 4- (T2) and 8-weeks (T3) follow-ups after surgery ]
    the energy expenditure related to physical activities of daily living, measured in kilocalories/kg/week.

  14. The Clavien-Dindo Classifications(CDC) [ Time Frame: During the post-operative period, data collected on average up to 2 months after the surgery date. ]
    The Clavien-Dindo Classifications(CDC) indicates the resource utilization of complication post-operatively, ranging from 0 to 4 (4 being patient admitted to the intensive care).

  15. The Comprehensive Complication Index (CCI) [ Time Frame: During the post-operative period, data collected on average up to 2 months after the surgery date. ]
    The comprehensive complication index (CCI) is a score of the r severity of post-operative complications, ranging from 0 to 100 (100 being mortality).

  16. The 30-day Mortality [ Time Frame: During the post-operative period, for a month after the surgery date. ]
    The 30-day mortality will assess the number of deaths within the first 30 days post-surgery.

  17. Length of Intensive Care Stay [ Time Frame: During the post-operative period, data collected on average up to 2 months after the surgery date. ]
    Length of intensive care stay will be assessed as the number of hours from arrival to the unit.

  18. Days with a chest tube [ Time Frame: During the post-operative period, data collected on average up to 2 months after the surgery date. ]
    Days with a chest tube will be assessed as the number of days and hours for the last day, if applicable.

  19. Length of Hospital Stay [ Time Frame: During the post-operative period, data collected on average up to 2 months after the surgery date. ]
    Length of Hospital Stay will be assessed as a number of post-operative hours until discharge



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults scheduled for elective cancer surgery that is delayed due to COVID-19 referred by a surgeon;
  • Covered by the RAMQ
  • Have medical clearance to exercise (as provided on the physician referral);
  • Are able to understand English or French.

Exclusion Criteria:

  • N.A.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04799561


Contacts
Layout table for location contacts
Contact: Francesco Carli, MD, MPhil 514-934-1934 ext 43728 franco.carli@mcgill.ca

Locations
Layout table for location information
Canada, Quebec
Muhc-Rimuhc Recruiting
Montréal, Quebec, Canada, H3G 1A4
Contact: Francesco Carli, MD    5149341934 ext 44188    franco.carli@mcgill.ca   
Sponsors and Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre
Montreal General Hospital
Peri Operative Program, Montreal
  Study Documents (Full-Text)

Documents provided by Franco Carli, McGill University Health Centre/Research Institute of the McGill University Health Centre:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Franco Carli, Principal Investigator and Professor of Anesthesia, McGill University Health Centre/Research Institute of the McGill University Health Centre
ClinicalTrials.gov Identifier: NCT04799561    
Other Study ID Numbers: MUHC-2021-6730
First Posted: March 16, 2021    Key Record Dates
Last Update Posted: September 30, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Franco Carli, McGill University Health Centre/Research Institute of the McGill University Health Centre:
Telehealth
Telemedecine
Prehabilitation
Supportive Care